ONC
BeOne Medicines Ltd
280 hedge funds and large institutions have $10.3B invested in BeOne Medicines Ltd in 2025 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 111 increasing their positions, 69 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
1.55% less ownership
Funds ownership: 30.09% → 28.53% (-1.6%)
9% less capital invested
Capital invested by funds: $11.2B → $10.3B (-$957M)
23% less call options, than puts
Call options by funds: $34.3M | Put options by funds: $44.9M
Holders
280
Holding in Top 10
7
Calls
$34.3M
Puts
$44.9M
Top Buyers
| 1 | +$163M | |
| 2 | +$68M | |
| 3 | +$59M | |
| 4 |
Goldman Sachs
New York
|
+$34.2M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$31.8M |
Top Sellers
| 1 | -$84.4M | |
| 2 | -$52.4M | |
| 3 | -$36.8M | |
| 4 |
Primecap Management
Pasadena,
California
|
-$32.7M |
| 5 |
Temasek Holdings
Singapore
|
-$30.1M |
